Safety and activity of alectinib plus bevacizumab in patients with advanced ALK-rearranged non-small-cell lung cancer: a phase I/II study
暂无分享,去创建一个
C. Azzoli | L. Sequist | A. Shaw | J. Lin | I. Lennes | J. Gainor | I. Dagogo-Jack | A. Muzikansky | L. Stober | E. Kennedy | H. Kuberski | A. C. Wanat